The potential role of interleukin-13 in eosinophilic inflammation in nasal mucosa

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 7, 1998, Pages 690-697

  Terada, N ^a   Hamano, N ^a   Hohki, G ^a   Ikeda, T ^b   Sai, M ^b   Yamashita, T ^c   Konno, A ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Morinaga Bio Sci Laboratories Inc   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Adhesion molecule; Endothelial cells; Eosinophil; Interleukin 13; Nasal allergy; Vascular cell adhesion molecule 1

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL MIGRATION; ENDOTHELIUM CELL; EOSINOPHILIA; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; NOSE MUCOSA; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0031823166     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03955.x     Document Type: Article

References (24)

1. Konno A, Terada N, Ito E, Okamoto Y, Togawa K. The reaction of the nasal mucosa to platelet activating factor and leukotrienes in nasal allcrgy. ORL Tokyo 1988;31 Suppl 7:241-2.
2. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 1992;90:160-8.
3. Terada N, Konno A, Togawa K. Biochemical properties of cosinophils and mechanism of their preferential accumulation in nasal allergy. J Allergy Clin Immunol 1994;94:629-42.
4. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, et al. Interleukin-13: a T-cell-derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci U S A 1993;90:3735-9.
5. Cocks BG, de Waal Malefyt R, Galizzi JP, de Vries JE. IL-13 induces proliferation and differentiation of human B cells. Int Immunol 1993;5:657-63.
6. Defrance T, Carayon P, Billian G, Guillemot JC, Minty A, Caput D. Interleukin-13 is a B-cell-stimulating factor. J Exp Med 1994;179:135-43.
7. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan PS, Bennett B. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993;151:6370-81.
8. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune response. Nature 1993;362:248-50.
9. Punnonen J, Anersa G, Cocks BG, et al. Interleukin-13 induces IL-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 1994;90:3730-4.
10. Sironi M, Sciacca FL, Matteucci C, et al. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994;84: 1913-21.
11. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
12. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cullured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation anligen-4 integrin receptor. J Clin Invest 1991;88:20-7.
13. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148:1086-92.
14. Hansel TT, de Vries IJM, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-10.
15. Fukuda K, Imamura Y, Koshihara Y, Ooyama T, Hanamure Y, Ohyama M. Establishment of human mucosal microvascular endothelial cells from inferior turbinate in culture. Am J Otolaryngol 1989;10:85-91.
16. Terada N, Maesako K, Hamano N, et al. Eosinophil adhesion regulates RANTES production in nasal epithelial cells. J Immunol 1997;158:5464-70.
17. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 1994;153:2153-60.
18. Sung KL, Yang L. Elices M, Jin G, Sriramarao P, Broide DH. Granulocyte-macrophage colony stimulating factor regulates the functional adhesive state of very late antigen-4 expressed by eosinophils. J Immunol 1997;158: 919-27.
19. Masumoto A, Hemler ME. Multiple activation states of VLA-4: mechanistic differences between adhesion to CS1/ fibronectin and to vascular cell adhesion molecule-1. J Biol Chem 1993;268:228-34.
20. Luttmann W, Knoechel B, Foerster M, Matthys H, Virchow JC Jr, Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface anligen, ils relalionship to messenger RNA expression, and promotion of cellular viability. J Immunol 1996;157:1678-83.
21. Kroegel C, Julius P, Matthys H, Virchow JC Jr, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur Respir J 1996;9: 899-904.
22. Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2059-67.
23. εRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997;99: 1492-9.
24. Roberts BA, Moritz RL, Simpson RJ, Alexander WS, Metcalf D, Nicola NA. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha-chains. J Biol Chem 1997;272:9474-80.